NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

I have promoted to vote No for authorization to increase share counts and I have firmed my position after yesterday's disgusting no-end dilutive financing with deep discount to market price, though in a tiny dilution.

By saying that I have drawn the ire of of many posters in this board, which I strongly disagreed. By cheering any actions Linda has done, particularly her repeated failures in securing non-dilute funds with the results of unprecedented huge dilution to all investors except herself who has miraculously emerged as the control stakeholder again while all other investors have experienced unimaginable dilution.

Linda job well done for yourself and a few of her associates!

We must not encourage her irresponsible action and must vote no, which after yesterday's disposition financing may come any day for a vote as she must think she has secured enough votes.

I believe there are always ways, non-dilute ways of financing with a promising treatment on the cusp of final results with huge market implication;

Unfortunately, she has failed, simply unwilling to take her due risks.

It's no doubt at this point that she has enriched herself, only herself:

1) She is the largest stakeholder of nwbo;
2) She gets paid from so-called management buyout from Cognate in an undisclosed amount and/or derivatives ;
3) She may have had her money back from early investment and more.
4) She will be the biggest beneficiary if DCVax-L trial is successful, which I have no problem.

At the same time, we have continually suffered in many fronts in various magnitudes of which most are avoidable and repetitive!

If Linda ever issues a cent of more dilution, I would like to ask the whole management and board members of nwbo to forego their monthly salaries, cancel all unnecessary activities such as conference, exhibition, sponsorship, etc., and focus on making the publication a reality and bringing the trial to un-blinding ASAP.

If the trial is successful, you will have your salaries back plus interests.

If the company is still short of fund to achieve 1) the publication; and 2) unblinding the trial, then it shall re-mortgage UK facility, or any other way of the nature of non dilution.

BTW, who is or are yesterday's financiers?